Minoxidil vs Finasteride vs Dutasteride: Gupta 2025 Network Meta-Analysis Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Journal of Cosmetic Dermatology, 2025
Minoxidil vs Finasteride vs Dutasteride: Gupta 2025 Network Meta-Analysis Research Summary
Study conclusion
This network meta-analysis compared all doses and delivery routes of minoxidil, finasteride, and dutasteride for male pattern hair loss across 33 eligible studies. Oral dutasteride 0.5mg daily ranked as the most effective overall option. Among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy and oral finasteride 1mg was the most effective FDA-approved oral option.
Strength of evidence
Who it applies to
Who was studied
Men with male pattern hair loss. 33 eligible studies included. All doses and routes of minoxidil, finasteride, and dutasteride compared. Primary outcomes: hair density change at 24 and 48 weeks.
Who was NOT studied
Women with pattern hair loss. People using combination therapies. Treatments other than the three drugs studied.
What to look for when shopping
Only topical minoxidil 2% and 5% and oral finasteride 1mg are FDA-approved for male pattern hair loss. Dutasteride is not FDA-approved for hair loss in the US. All prescription treatments require a doctor.
What research cannot help you decide
Whether dutasteride's higher efficacy justifies its off-label use and associated side effects for your situation. This requires discussion with a prescribing doctor.
Key findings
- Oral dutasteride 0.5mg daily ranked as the most effective option overall across all treatments studied
- Among FDA-approved treatments, topical minoxidil 5% was the most effective topical monotherapy
- Oral finasteride 1mg was the most effective FDA-approved oral option
- Dutasteride injected into the scalp (mesotherapy) was significantly less effective than oral dutasteride
- Dutasteride is not FDA-approved for hair loss in the US — finasteride 1mg is the only FDA-approved oral treatment
What this study does not show
- 1.Whether dutasteride is safe for long-term use as a hair loss treatment — it is not FDA-approved for this purpose.
- 2.How treatments compare when used in combination — this NMA studied monotherapy only.
- 3.How any of these treatments compare to non-pharmaceutical options like red light therapy or PRP.
Limitations
- 1.Network meta-analysis uses indirect comparisons — some treatments were never directly compared.
- 2.Dutasteride is not FDA-approved for hair loss in the US.
- 3.Only male patients studied — results do not apply to women.
- 4.Evidence on some treatment nodes was sparse, increasing uncertainty in those rankings.
Used in these articles
Links added as fact-checks and articles citing this study are published.